Gregory Scott Duncan - 27 Jun 2025 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Reporting relationship
CHIEF EXECUTIVE OFFICER, Director
Issuer ticker
DWTX
Reported as of
27 Jun 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jul 2025, 14:00:33 UTC
Prior SEC filing
22 Jan 2025
Next SEC filing
18 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Greg Duncan

Key filing fact

Gregory Scott Duncan filed Form 4 for Dogwood Therapeutics, Inc. (DWTX) on 01 Jul 2025.

Key facts

  • This page summarizes Gregory Scott Duncan's Form 4 filing for Dogwood Therapeutics, Inc. (DWTX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 01 Jul 2025, 14:00.

Change

  • Previous filing in this sequence was filed on 22 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001831127 Primary reporting owner

Duncan Gregory Scott

Relationship
CHIEF EXECUTIVE OFFICER, Director
Address
C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA
Signature
/s/ Greg Duncan
Signature date
01 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DWTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+40,000
Change %
Price
$0.000000
Shares after
40,000
Date
27 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$4.71
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .